ADC Therapeutics SA Quarterly Costs and Expenses in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
ADC Therapeutics SA quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q3 2024.
  • ADC Therapeutics SA Costs and Expenses for the quarter ending September 30, 2024 was $54M, a 6.69% increase year-over-year.
  • ADC Therapeutics SA Costs and Expenses for the twelve months ending September 30, 2024 was $209M.
  • ADC Therapeutics SA annual Costs and Expenses for 2023 was $236M, a 29.3% decline from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $209M $54M +$3.39M +6.69% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $206M $46.5M -$12.5M -21.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $218M $51.7M -$17.5M -25.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $236M $56.8M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $50.6M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $58.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $69.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.